首页 | 本学科首页   官方微博 | 高级检索  
     

维胺酯胶囊治疗脂溢性皮炎安全性及可行性分析
引用本文:李艳伟. 维胺酯胶囊治疗脂溢性皮炎安全性及可行性分析[J]. 中国基层医药, 2014, 0(21): 3251-3253
作者姓名:李艳伟
作者单位:绍兴市上虞区第二人民医院皮肤科, 浙江省绍兴,312365
摘    要:目的:探讨维胺酯胶囊治疗脂溢性皮炎及可行性分析安全性。方法根据数字表法将84例脂溢性皮炎患者随机分为观察组和对照组,各42例,对照组患者给予1%吡美莫司乳膏外涂,2次/d;观察组在对照组基础上口服维胺酯胶囊50 mg/次,2次/d,2周为1个疗程,连续用药2个疗程。观察两组患者疗效和不良反应。结果观察组治疗4周、8周后红斑、鳞屑、皮脂溢、瘙痒等症状积分及总积分显著低于对照组(红斑t=5.865、5.786,鳞屑t=6.112、5.886,皮脂溢t=5.963、5.629,瘙痒t=6.123、6.072,均P<0.05)。观察组治疗1周、4周、8周总有效率分别为57.14%、85.71%、95.24%,对照组分别为42.86%、59.52%、80.95%,差异均有统计学意义(χ2=5.632、6.986、5.252,均P<0.05)。观察组复发率为2.38%,低于对照组的19.05%;满意率100.00%,高于对照组的76.19%,差异均有统计学意义(χ2=5.986、6.123,均P<0.05)。而两组不良反应发生率差异无统计学意义(χ2=0.589,P>0.05)。结论维胺酯胶囊能在较短的时间内改善脂溢性皮炎患者临床症状,效果显著,复发率低,安全有效。

关 键 词:皮炎,脂溢性  维胺酯胶囊

The safety and feasibility analysis of viaminate capsule in the treatment of seborrheic dermatitis
Li Yanwei. The safety and feasibility analysis of viaminate capsule in the treatment of seborrheic dermatitis[J]. Chinese Journal of Primary Medicine and Pharmacy, 2014, 0(21): 3251-3253
Authors:Li Yanwei
Affiliation:Li Yanwei(Department of Dermatology, the Second People s Hospital of Shansyu District, Shaoxing, Zhejiang 312365, China)
Abstract:Objective To investigate the safety and feasibility of viaminate capsule in the treatment of sebor-rheic dermatitis.Methods According to the digital table, 84 patients with seborrheic dermatitis were randomly divided into the observation group(n=42) and the control group(n=42).The control group were treated with 1%pimecrolimus cream coated, 2 times/d.The observation group were treated with capsule viaminate, 50mg/times, 2 times/d,2 weeks for a course of treatment.The clinical efficacy of the two groups were observed.Results The ery thema,scaling,seborrhea,itching and other symptoms score and total score after treatment to 4 weeks,8 weeks of the two groups were compared(Erythema t=5.865,5.786;scaly t=6.112,5.886;seborrhea t=5.963,5.629;itching t=6.123,6.072.all P〈0.05).The total effective rate of treatment 1 week,4 weeks,8 weeks of observation group were 57.14%,85.71%,95.24%.The control group were 42.86%,59.52%,80.95%,the difference was statistical-ly significant(χ2 =5.632,6.986,5.252,all P 〈0.05).The patients relapse rate of the observation group was 2.38%,which was lower than 19.05%of the control group(χ2 =5.986,P〈0.05),and the satisfaction rate of the observation group was 100.00%,which was higher than 76.19%of the control group(χ2 =6.123,P〈0.05),but the adverse effects of the two groups had no statistically significant(χ2 =0.589,P〉0.05).Conclusion Viaminate cap-sule can improve in a short period of time in patients with clinical symptoms of seborrheic dermatitis,the effect is sig-nificant,the recurrence rate is low,safe and effective.
Keywords:Dermatitis,Seborrheic  Viaminate Capsules
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号